NYSE - Delayed Quote • USD
CVS Health Corporation (CVS)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
357,776,000.00
357,776,000.00
322,467,000.00
292,111,000.00
268,706,000.00
Cost of Revenue
303,345,000.00
303,345,000.00
267,965,000.00
239,991,000.00
219,660,000.00
Gross Profit
54,431,000.00
54,431,000.00
54,502,000.00
52,120,000.00
49,046,000.00
Operating Expense
39,832,000.00
39,832,000.00
38,212,000.00
37,021,000.00
35,135,000.00
Operating Income
14,599,000.00
14,599,000.00
16,290,000.00
15,099,000.00
13,911,000.00
Net Non Operating Interest Income Expense
-2,658,000.00
-2,658,000.00
-2,287,000.00
-2,503,000.00
-2,907,000.00
Other Income Expense
-768,000.00
-768,000.00
-8,167,000.00
-2,059,000.00
-1,234,000.00
Pretax Income
11,173,000.00
11,173,000.00
5,836,000.00
10,537,000.00
9,770,000.00
Tax Provision
2,805,000.00
2,805,000.00
1,509,000.00
2,548,000.00
2,569,000.00
Net Income Common Stockholders
8,344,000.00
8,344,000.00
4,311,000.00
8,001,000.00
7,179,000.00
Diluted NI Available to Com Stockholders
8,344,000.00
8,344,000.00
4,311,000.00
8,001,000.00
7,179,000.00
Basic EPS
6.49
6.49
3.29
6.07
5.48
Diluted EPS
6.47
6.47
3.26
6.02
5.46
Basic Average Shares
1,285,000.00
1,285,000.00
1,312,000.00
1,319,000.00
1,309,000.00
Diluted Average Shares
1,290,000.00
1,290,000.00
1,323,000.00
1,329,000.00
1,314,000.00
Total Operating Income as Reported
13,743,000.00
13,743,000.00
7,954,000.00
13,310,000.00
13,911,000.00
Total Expenses
343,177,000.00
343,177,000.00
306,177,000.00
277,012,000.00
254,795,000.00
Net Income from Continuing & Discontinued Operation
8,344,000.00
8,344,000.00
4,311,000.00
8,001,000.00
7,179,000.00
Normalized Income
8,985,144.00
8,985,144.00
10,487,976.00
9,699,678.00
8,249,280.00
Interest Expense
2,658,000.00
2,658,000.00
2,287,000.00
2,503,000.00
2,907,000.00
Net Interest Income
-2,658,000.00
-2,658,000.00
-2,287,000.00
-2,503,000.00
-2,907,000.00
EBIT
13,831,000.00
13,831,000.00
8,123,000.00
13,040,000.00
12,677,000.00
EBITDA
18,197,000.00
18,197,000.00
12,347,000.00
17,526,000.00
17,118,000.00
Reconciled Cost of Revenue
303,345,000.00
303,345,000.00
267,965,000.00
239,991,000.00
219,660,000.00
Reconciled Depreciation
4,366,000.00
4,366,000.00
4,224,000.00
4,486,000.00
4,441,000.00
Net Income from Continuing Operation Net Minority Interest
8,344,000.00
8,344,000.00
4,311,000.00
8,001,000.00
7,188,000.00
Total Unusual Items Excluding Goodwill
-856,000.00
-856,000.00
-8,336,000.00
-2,241,000.00
-1,440,000.00
Total Unusual Items
-856,000.00
-856,000.00
-8,336,000.00
-2,241,000.00
-1,440,000.00
Normalized EBITDA
19,053,000.00
19,053,000.00
20,683,000.00
19,767,000.00
18,558,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-214,856.00
-214,856.00
-2,159,024.00
-542,322.00
-378,720.00
12/31/2020 - 2/21/1973
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UNH UnitedHealth Group Incorporated
487.30
+0.23%
HUM Humana Inc.
315.98
-3.66%
CI The Cigna Group
352.28
-0.10%
ELV Elevance Health, Inc.
533.73
+0.15%
CNC Centene Corporation
76.19
+0.46%
OSCR Oscar Health, Inc.
17.59
+1.09%
MOH Molina Healthcare, Inc.
367.41
+1.15%
CLOV Clover Health Investments, Corp.
0.6500
+3.19%
ALHC Alignment Healthcare, Inc.
5.18
0.00%
NEUE NeueHealth, Inc.
6.46
+5.04%